NeuClone Starts Trial For Ustekinumab Biosimilar

NeuLara Rival To Stelara Enters Phase I Clinical Trial

People_Orange_Icon
NeuClone’s NeuLara enters the clinical development stage • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products